Literature DB >> 7735699

Differentiation by pyridoxal 5-phosphate, PPADS and IsoPPADS between responses mediated by UTP and those evoked by alpha, beta-methylene-ATP on rat sympathetic ganglia.

G P Connolly1.   

Abstract

1. The effect of pyridoxal 5-phosphate, and the 2',4' and 2',5'-disulphonic acid isomers of 6-azophenylpyridoxal 5-phosphate (PPADS and IsoPPADS respectively) on depolarization of the rat superior cervical ganglion evoked by alpha, beta-methylene-adenosine 5'-triphosphate (alpha, beta-Me-ATP) and uridine 5'-triphosphate (UTP) were determined by a grease-gap recording technique. 2. Pyridoxal 5-phosphate (10-100 microM) and PPADS (10-100 microM) enhanced UTP- and depressed alpha, beta-Me-ATP-evoked depolarizations but did not significantly alter depolarizations evoked by potassium or hyperpolarizations evoked by adenosine. IsoPPADS (10 microM) depressed alpha, beta-Me-ATP-evoked depolarizations but did not alter depolarizations evoked by UTP. Depolarizations evoked by muscarine were depressed by IsoPPADS but not by pyridoxal 5-phosphate. 3. It is concluded that pyridoxal 5-phosphate, PPADS and IsoPPADS are antagonists at P2x-purinoceptors but not at the receptors that mediate UTP-evoked depolarization of the rat superior cervical ganglion. These observations substantiate the recent proposal that the rat superior cervical ganglia possess distinct receptors for purine and pyrimidine 5'-nucleotides, i.c. P2x-purinoceptors and pyrimidinoceptors respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7735699      PMCID: PMC1510023          DOI: 10.1111/j.1476-5381.1995.tb17199.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

1.  The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency.

Authors:  L A Welford; N J Cusack; S M Hourani
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

Review 2.  Is there a basis for distinguishing two types of P2-purinoceptor?

Authors:  G Burnstock; C Kennedy
Journal:  Gen Pharmacol       Date:  1985

3.  Evidence for two separate vasoconstriction-mediating nucleotide receptors, both distinct from the P2x-receptor, in rabbit basilar artery: a receptor for pyrimidine nucleotides and a receptor for purine nucleotides.

Authors:  I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

Review 4.  Further subclassification of ATP receptors based on agonist studies.

Authors:  S E O'Connor; I A Dainty; P Leff
Journal:  Trends Pharmacol Sci       Date:  1991-04       Impact factor: 14.819

5.  A novel extracellular nucleotide receptor coupled to phosphoinositidase-C in pituitary cells.

Authors:  J S Davidson; I K Wakefield; U Sohnius; P A van der Merwe; R P Millar
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

6.  The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder.

Authors:  S M Hourani; J A Chown
Journal:  Gen Pharmacol       Date:  1989

7.  Actions of extracellular UTP and ATP in perfused rat liver. A comparative study.

Authors:  D Häussinger; T Stehle; W Gerok
Journal:  Eur J Biochem       Date:  1987-08-17

Review 8.  Involvement of pyrimidinoceptors in the regulation of cell functions by uridine and by uracil nucleotides.

Authors:  R Seifert; G Schultz
Journal:  Trends Pharmacol Sci       Date:  1989-09       Impact factor: 14.819

9.  Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.

Authors:  I von Kügelgen; D Häussinger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-11       Impact factor: 3.000

10.  Reactive blue 2 discriminates between responses mediated by UTP and those evoked by ATP or alpha,beta-methylene-ATP on rat sympathetic ganglia.

Authors:  G P Connolly; P J Harrison
Journal:  Eur J Pharmacol       Date:  1994-06-23       Impact factor: 4.432

View more
  11 in total

1.  Evaluation of P2-purinoceptor antagonists at two relaxation-mediating P2-purinoceptors in guinea-pig taenia coli.

Authors:  R Bültmann; O Dudeck; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

2.  Co-existence of P2Y-and PPADS-insensitive P2U-purinoceptors in endothelial cells from adrenal medulla.

Authors:  J Mateo; M T Miras-Portugal; E Castro
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Purinergic control of vascular tone in the retina.

Authors:  Joanna Kur; Eric A Newman
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

Review 4.  Uridine nucleotide receptors and their ligands: structural, physiological, and pathophysiological aspects, with special emphasis on the nervous system.

Authors:  E Heilbronn; B H Knoblauch; C E Müller
Journal:  Neurochem Res       Date:  1997-08       Impact factor: 3.996

5.  UTP- and ATP-triggered transmitter release from rat sympathetic neurones via separate receptors.

Authors:  S Boehm; S Huck; P Illes
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  P2 receptor excitation of rodent hypoglossal motoneuron activity in vitro and in vivo: a molecular physiological analysis.

Authors:  G D Funk; R Kanjhan; C Walsh; J Lipski; A M Comer; M A Parkis; G D Housley
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

7.  Diadenosine polyphosphate-stimulated gluconeogenesis in isolated rat proximal tubules.

Authors:  M Edgecombe; H S Craddock; D C Smith; A G McLennan; M J Fisher
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

8.  P2x-purinoceptors of myenteric neurones from the guinea-pig ileum and their unusual pharmacological properties.

Authors:  C Barajas-López; J D Huizinga; S M Collins; V Gerzanich; R Espinosa-Luna; A L Peres
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

9.  PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.

Authors:  C Brown; B Tanna; M R Boarder
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

10.  Structure-activity relationship of a pyrimidine receptor in the rat isolated superior cervical ganglion.

Authors:  G P Connolly; P J Harrison
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.